Brittany Avin McKelvey, Senior Director of Regulatory Policy at LUNGevity Foundation, shared a post on Linkedin:
” I’m looking forward to attending the AACR Annual Meeting with LUNGevity Foundation!
On April 20th, I’ll be presenting our analysis showing a concerning trend towards consolidation of early phase non-small cell lung cancer trials at top-performing US sites and an overall recent loss of clinical trial sites across the country.
I hope to see you at the poster or catch up for coffee or a chat, feel free to reach out.”
